Cita APA

Vordermark, D., Ruprecht, K., Rieckmann, P., Roggendorf, W., Vince, G. H., Warmuth-Metz, M., . . . Flentje, M. (2006). Glioblastoma multiforme with oligodendroglial component (GBMO): Favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26). BioMed Central.

Citación estilo Chicago

Vordermark, Dirk, Klemens Ruprecht, Peter Rieckmann, Wolfgang Roggendorf, Giles H. Vince, Monika Warmuth-Metz, Oliver Kölbl, and Michael Flentje. Glioblastoma Multiforme With Oligodendroglial Component (GBMO): Favorable Outcome After Post-operative Radiotherapy and Chemotherapy With Nimustine (ACNU) and Teniposide (VM26). BioMed Central, 2006.

Cita MLA

Vordermark, Dirk, et al. Glioblastoma Multiforme With Oligodendroglial Component (GBMO): Favorable Outcome After Post-operative Radiotherapy and Chemotherapy With Nimustine (ACNU) and Teniposide (VM26). BioMed Central, 2006.

Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.